Cited by 1,190Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

Standards of Medical Care in Diabetes—2007

Open access
American Diabetes Association·2007·Diabetes Care

Abstract

GESTATIONAL DIABETES MELLITUS, p. S7 IV.PREVENTION/DELAY OF TYPE 2 DIABETES, p. S7 V. DIABETES CARE, p. S8 A. Initial evaluation B. Management C. Glycemic control 1. Assessment of glycemic control a. Self-monitoring of blood glucose b.A1C 2. Glycemic goals 3. Approach to treatment D. Medical nutrition therapy E. Diabetes self-management education F. Physical activity G. Psychosocial assessment and care H. Referral for diabetes management I. Intercurrent illness

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc07-s004

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intensified multifactorial intervention with tight glucose regulation and the use of renin-angiotensin system blockers, aspirin, and lipid-lowering agents has been shown to reduce the risk of nonfatal cardiovascular disease among patients with type 2 diabetes mellitus and microalbuminuria.

    “Intensified multifactorial intervention -with tight glucose regulation and the use of renin-angiotensin system blockers, aspirin, and lipid-lowering agents -has been shown to reduce the risk of nonfatal cardiovascular disease among patients with type 2 diabetes mellitus and microalbuminuria.”

    From Effect of a multifactorial intervention on mortality in type 2 diabetes (2008) · cites this paper as [10]

    The CVD section (page unavailable) says reducing cardiovascular risk factors can prevent or slow CVD and reports cardiovascular benefits from lipid-lowering and blood-pressure treatment. The antiplatelet section also reports that aspirin helps prevent cardiovascular events. The copy does not establish that the specified combined intervention reduced nonfatal CVD specifically in patients with type 2 diabetes and microalbuminuria. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The risk of vascular complications was reduced by about half in the Steno-2 Study during an average of 7.8 years of intensified multitarget intervention aimed at concomitant risk factors.

    “Furthermore, the risk of vascular complications was reduced by about half in the Steno-2 Study, our previous prospective, randomized, open-label, blinded trial, during an average of 7.8 years of intensified multitarget intervention aimed at concomitant risk factors.10”

    From Effect of a multifactorial intervention on mortality in type 2 diabetes (2008) · cites this paper as [10]

    The Glycemic goals section discusses intensive treatment and vascular complications in other studies, but it does not report the Steno-2 result. Searches of our copy for Steno, 7.8 years, and multifactorial intervention found no passage giving the claimed duration or approximately halved risk. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Few serious adverse effects were reported during regular interviews with patients.

    “However, few serious adverse effects were reported during regular interviews with patients.10,12”

    From Effect of a multifactorial intervention on mortality in type 2 diabetes (2008) · cites this paper as [10]

    The ‘C. Older individuals’ section discusses the risk of serious adverse effects from hypoglycemia, but does not report how many adverse effects occurred. Searches for regular patient interviews and reports of few serious adverse effects found no passage addressing either point. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 21

  1. Bode BW (Ed.):Medical Management of Type 1 Diabetes. Alexandria, VA, Ameri- can Diabetes Association, 2004
  2. Burant CF (Ed.):Medical Management of Type 2 Diabetes. Alexandria, VA, Ameri- can Diabetes Association, 2004
  3. Klingensmith GJ (Ed.): Intensive Diabetes Management. Alexandria, VA, American Diabetes Association, 2003
  4. Harris R, Donahue K, Rathore SS, Frame P, Woolf SH, Lohr KN: Screening adults for type 2 diabetes: a review of the evi- dence for the U.S. Preventive Services Task Force. Ann Intern Med 138: 215-229, 2003
  5. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, Bouter LM: Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 28:1510 -1517, 2005
  6. Lawson ML, Gerstein HC, Tsui E, Zin- man B: Effect of intensive therapy on early macrovascular disease in young in- dividuals with type 1 diabetes: a system- atic review and meta-analysis. Diabetes Care 22 (Suppl. 2):B35-B39, 1999
  7. Metzger BE, Coustan DR: Summary and recommendations of the Fourth Interna- tional Workshop-Conference on Gesta- tional Diabetes Mellitus: the Organizing Committee. Diabetes Care 21 (Suppl. 2): B161-B167, 1998
  8. Jovanovic-Peterson L. (Ed.): Medical Management of Pregnancy Complicated by Diabetes. 3rd ed. Alexandria, VA, Amer- ican Diabetes Association, 2000
  9. Mooradian AD, Bernbaum M, Albert SG: Narrative review: a rational approach to starting insulin therapy. Ann Intern Med 145:125-134, 2006
  10. Institute of Medicine: Dietary Reference Intakes: Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, D.C., Na- tional Academies Press, 2002
  11. Steed L, Cooke D, Newman S: A system- atic review of psychosocial outcomes fol- lowing education, self-management and psychological interventions in diabetes mellitus. Patient Educ Couns 51:5-15, 2003
  12. Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH: Self-management edu- cation programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med 164:1641-1649, 2004
  13. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C: Physical activity/ exercise and type 2 diabetes (Technical Review). Diabetes Care 27:2518 -2539, 2004
  14. Fowler-Brown A, Pignone M, Pletcher M, Tice JA, Sutton SF, Lohr KN: Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Services Task Force. Ann Intern Med 140: W9 -W24, 2004
  15. Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, Lust- man PJ: Anxiety and poor glycemic con- trol: a meta-analytic review of the literature. Int J Psychiatry Med 32:235- 247, 2002
  16. Marcus MD, Wing RR: Eating disorders and diabetes. In Neuropsychological and Behavioral Aspects of Diabetes. Holmes CS, Ed. New York, Springer-Verlag, 1990, p. 102-121
  17. American Diabetes Asociation: Consen- sus development conference on the di- agnosis of coronary heart disease in people with diabetes: 10 -11 February 1998, Miami, Florida. Diabetes Care 21: 1551-1559, 1998
  18. Vinik AI, Mehrabyan A: Diabetic neu- ropathies (Review). Med Clin North Am 88:947-999, xi, 2004 173.
  19. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM: Preventive foot care in people with diabetes. Diabetes Care 21:2161-2177, 1998 176. American Diabetes Association: Preven- tive foot care in diabetes (Position State- ment). Diabetes Care 27 (Suppl. 1):S63- S64, 2004 177. American Diabetes Association: Consen- sus Development Conference on Dia- betic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. Diabetes Care 22:1354 -1360, 1999 178.
  20. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Beckles GL, Saaddine J, Gregg EW, Wil- liamson DF, Narayan KM: Type 2 diabe- tes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 136:664 -672, 2000 187.
  21. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsh IB: Management of diabetes and hyper- glycemia in hospitals. Diabetes Care 27: 553-591, 2004 197. American Association of Clinical En- docrinologists: Inpatient diabetes and metabolic control: conference pro- ceedings. Endocr Pract 10 (Suppl. 2): 1-108, 2004 198.

Cited by

Sorted by citations

Authors
American Diabetes Association
Corresponding author
American Diabetes Association
Venue
Diabetes Care
Published
2007-01-01
Volume
30
Issue
suppl_1
Pages
S4-S41
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W4210559565
Cited by
1,190
References
41
Citations by year
2026: 4 · 2025: 5 · 2024: 14 · 2023: 13 · 2022: 22 · 2021: 23 · 2020: 30 · 2019: 25 · 2018: 28 · 2017: 24 · 2016: 37 · 2015: 31 · 2014: 43 · 2013: 52 · 2012: 64
FWCI
137.34
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
diabetes mellitus, gestational diabetes mellitus, type 2 diabetes prevention, glycemic control, glycemic targets, HbA1c, self-monitoring of blood glucose, medical nutrition therapy, diabetes self-management education, physical activity, psychosocial assessment, intercurrent illness, diabetes management
MeSH terms
Adolescent, Adult, Child, Diabetes Mellitus, Diabetes Mellitus, Type 2, Female, Health Services, Humans, Male, Pregnancy, Quality of Health Care, Societies, Medical, United States, Voluntary Health Agencies, Age of Onset

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review